Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 939205, 7 pages
http://dx.doi.org/10.1093/ecam/neq011
Original Article

Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro

1Department of Hepatology and Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China
3Faculty of Pharmacy, Hubei College of Traditional Chinese Medicine, China

Received 29 September 2009; Accepted 31 January 2010

Copyright © 2011 Ran Pang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Arbuthnot, S. Carmona, and A. Ely, “Exploiting the RNA interference pathway to counter hepatitis B virus replication,” Liver International, vol. 25, no. 1, pp. 9–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. N. H. Park, I. H. Song, and Y. H. Chung, “Chronic hepatitis B in hepatocarcinogenesis,” Postgraduate Medical Journal, vol. 82, pp. 507–515, 2006. View at Google Scholar
  3. Y.-F. Liaw, “Therapy of chronic hepatitis B: current challenges and opportunities,” Journal of Viral Hepatitis, vol. 9, no. 6, pp. 393–399, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Chang, K. L. Huang, T. T. Yuan, Y. K. Lai, and L. M. Hung, “The anti-hepatitis B virus activity of boehmeria nivea extract in HBV-viremia SCID mice,” Evidence-Based Complementary and Alternative Medicine, vol. 7 (2010), no. 2, pp. 189–195, 2008. View at Publisher · View at Google Scholar
  5. J. Zhao, T. Liu, L. Ma et al., “Antioxidant and preventive effects of extract from Nymphaea candida flower on in-vitro immunological liver injury of rat primary hepatocyte cultures,” Evidence-Based Complementary and Alternative Medicine. In press.
  6. K. Chen, G. W. Plumb, R. N. Bennett, and Y. Bao, “Antioxidant activities of extracts from five anti-viral medicinal plants,” Journal of Ethnopharmacology, vol. 96, no. 1-2, pp. 201–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Yabe, K. Tanaka, and H. Matsui, “An ethanol-extract of Ampelopsis brevipedunculata (Vitaceae) berries decreases ferrous iron-stimulated hepatocyte injury in culture,” The Journal of Ethnopharmacology, vol. 59, pp. 147–159, 1998. View at Google Scholar
  8. M.-J. Wu, J.-H. Yen, L. Wang, and C.-Y. Weng, “Antioxidant activity of Porcelainberry (Ampelopsis brevipedunculata (Maxim.) Trautv.),” American Journal of Chinese Medicine, vol. 32, no. 5, pp. 681–693, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Yabe and H. Matsui, “Ampelopsis brevipedunculata (Vitaceae) extract inhibits a progression of carbon tetrachloride-induced hepatic injury in the mice,” Phytomedicine, vol. 7, no. 6, pp. 493–498, 2000. View at Google Scholar · View at Scopus
  10. N. Moolla, M. Kew, and P. Arbuthnot, “Regulatory elements of hepatitis B virus transcription,” Journal of Viral Hepatitis, vol. 9, no. 5, pp. 323–331, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. B. H. Choi, G. T. Park, and H. M. Rho, “Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter,” The Journal of Biological Chemistry, vol. 274, pp. 2858–2865, 1999. View at Google Scholar
  12. Y. S. Zhang, Q. Y. Zhang, L. Y. Li, B. Wang, Y. Y. Zhao, and D. A. Guo, “Simultaneous determination and pharmacokinetic studies of dihydromyricetin and myricetin in rat plasma by HPLC-DAD after oral administration of Ampelopsis grossedentata decoction,” Journal of Chromatography B, vol. 860, pp. 4–9, 2007. View at Google Scholar
  13. L. Pourcel, J.-M. Routaboul, V. Cheynier, L. Lepiniec, and I. Debeaujon, “Flavonoid oxidation in plants: from biochemical properties to physiological functions,” Trends in Plant Science, vol. 12, no. 1, pp. 29–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Sells, M.-L. Chen, and G. Acs, “Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 4, pp. 1005–1009, 1987. View at Google Scholar · View at Scopus
  15. J. Xu, J. Wang, F. Deng, Z. Hu, and H. Wang, “Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro,” Antiviral Research, vol. 78, no. 3, pp. 242–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Li, H. Huang, M. Feng, W. Zhou, X. Shi, and P. Zhou, “In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L,” Antiviral Research, vol. 79, no. 2, pp. 114–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. B. J. McMahon, “The natural history of chronic hepatitis B virus infection,” Hepatology, vol. 49, no. 5, pp. S45–S55, 2009. View at Google Scholar · View at Scopus
  18. C.-J. Chen, H.-I. Yang, J. Su et al., “Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA Level,” JAMA, vol. 295, no. 1, pp. 65–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. U. H. Iloeje, H.-I. Yang, J. Su, C.-L. Jen, S.-L. You, and C.-J. Chen, “Predicting cirrhosis risk based on the level of circulating hepatitis B viral load,” Gastroenterology, vol. 130, no. 3, pp. 678–686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. H. I. Yang, S. N. Lu, Y. F. Liaw et al., “Hepatitis B e antigen and the risk of hepatocellular carcinoma,” The New England Journal of Medicine, vol. 347, pp. 168–174, 2002. View at Google Scholar
  21. G. Chen, W. Lin, F. Shen, U. H. Iloeje, W. T. London, and A. A. Evans, “Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study,” The American Journal of Gastroenterology, vol. 101, pp. 1797–1803, 2006. View at Google Scholar
  22. M. Shamay, O. Barak, G. Doitsh, I. Ben-Dor, and Y. Shaul, “Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription,” The Journal of Biological Chemistry, vol. 277, no. 12, pp. 9982–9988, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Kramvis and M. C. Kew, “The core promoter of hepatitis B virus,” Journal of Viral Hepatitis, vol. 6, no. 6, pp. 415–427, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Su and J.-K. Yee, “Regulation of hepatitis B virus gene expression by its two enhancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 7, pp. 2708–2712, 1992. View at Google Scholar · View at Scopus
  25. A. J. Levine, “p53, the cellular gatekeeper for growth and division,” Cell, vol. 88, no. 3, pp. 323–331, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-H. Yoon, E.-S. Lee, D.-S. Lim, and Y.-S. Bae, “PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 19, pp. 7852–7857, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. W. Hsu, H. C. Huang, S. T. Chen, C. H. Wong, and H. F. Juan, “Ganoderma lucidum polysaccharides induce macrophage-like differentiation in human leukemia THP-1 cells via caspase and p53 activation,” Evidence-Based Complementary and Alternative Medicine. In press.
  28. A. Takaoka, S. Hayakawa, H. Yanai et al., “Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence,” Nature, vol. 424, no. 6948, pp. 516–523, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. J. T. Marques, D. Rebouillat, C. V. Ramana et al., “Down-regulation of p53 by double-stranded RNA modulates the antiviral response,” Journal of Virology, vol. 79, no. 17, pp. 11105–11114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. N. C. Casavant, M. H. Luo, K. Rosenke, T. Winegardner, A. Zurawska, and E. A. Fortunato, “Potential role for p53 in the permissive life cycle of human cytomegalovirus,” Journal of Virology, vol. 80, no. 17, pp. 8390–8401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. Royds, M. Hibma, B. R. Dix et al., “p53 promotes adenoviral replication and increases late viral gene expression,” Oncogene, vol. 25, no. 10, pp. 1509–1520, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. J. Groskreutz, M. M. Monick, T. O. Yarovinsky et al., “Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells,” Journal of Immunology, vol. 179, no. 5, pp. 2741–2747, 2007. View at Google Scholar · View at Scopus
  33. M. L. Nguyen, R. M. Kraft, M. Aubert, E. Goodwin, D. DiMaio, and J. A. Blaho, “p53 and hTERT determine sensitivity to viral apoptosis,” Journal of Virology, vol. 81, no. 23, pp. 12985–12995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Dharel, N. Kato, R. Muroyama et al., “Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus,” Hepatology, vol. 47, no. 4, pp. 1136–1149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Pampin, Y. Simonin, B. Blondel, Y. Percherancier, and M. K. Chelbi-Alix, “Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense,” Journal of Virology, vol. 80, no. 17, pp. 8582–8592, 2006. View at Publisher · View at Google Scholar · View at Scopus